Although few studies have described the prognostic value of CTLA-4 levels in the tumor site, its expression has been associated with decreased survival in patients with nasopharyngeal carcinoma and increased survival in those with non-small-cell lung cancer (52). Here, CTLA4 is linked to neoplasm.